Continuous Glucose Monitors for Uncontrolled Type 2 Diabetes
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must be willing to follow any medication adjustments your provider suggests.
What data supports the effectiveness of the treatment Continuous Glucose Monitor (CGM) for uncontrolled Type 2 Diabetes?
Is continuous glucose monitoring safe for humans?
Continuous glucose monitors (CGMs) are generally considered safe for people with diabetes, though some users report mild discomfort or skin irritation. They are a low-pain method and have been used safely across various age groups, but there are some limitations like sensor accuracy and the need for calibration.678910
How is the Continuous Glucose Monitor (CGM) treatment different from other treatments for uncontrolled Type 2 Diabetes?
The Continuous Glucose Monitor (CGM) treatment is unique because it continuously tracks glucose levels in real-time, providing immediate feedback and alerts, unlike traditional methods that require manual blood sugar checks. This allows for more precise and timely management of diabetes, helping to improve glucose control and reduce the risk of low blood sugar episodes.211121314
What is the purpose of this trial?
This non-blinded, non-randomized pre-post study will examine the impact of providing CGM sensors free of charge to adult patients of Fair Haven Community Health Care with poorly controlled type 2 diabetes on glycemic control and quality of life.
Research Team
Kasia Lipska, MD MHS
Principal Investigator
Yale University
Eligibility Criteria
This trial is for adults with poorly controlled type 2 diabetes who are patients at Fair Haven Community Health Care. It's designed to see if using a Continuous Glucose Monitor (CGM) helps manage their condition better.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive CGM sensors and are instructed on their use. Medication adjustments are made based on CGM data.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with additional A1c measurements and questionnaire completions.
Treatment Details
Interventions
- Continuous Glucose Monitor (CGM)
Continuous Glucose Monitor (CGM) is already approved in United States, European Union, Canada for the following indications:
- Type 1 diabetes
- Type 2 diabetes
- Glycemic control
- Hypoglycemia prevention
- Type 1 diabetes
- Type 2 diabetes
- Glycemic control
- Hypoglycemia prevention
- Type 1 diabetes
- Type 2 diabetes
- Glycemic control
- Hypoglycemia prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
Yale Office of Global Health
Collaborator